New Medicines, Novel Insights: Accelerating Development Of Cell And Gene Therapies

Cell and gene therapies (CAGTs) offer remarkable promise to patients with advanced cancers and genetic diseases, and enthusiasm for these treatments has never been higher. With recent approvals across various gene and cell therapies, we are moving toward a transformative era in patient care. CAGTs have the potential to redefine medicine, and it is crucial that we remain committed to advancing this critical field.

However, CAGTs present unprecedented challenges for sponsors. Financial pressures are tightening pipelines, making it essential to make strategic decisions about which assets to advance and how to develop them effectively.

At Parexel, we believe that collaboration within the broader CAGT ecosystem will provide significant advantages both now and in the future. We are committed to developing innovative protocols and working closely with our sponsors to achieve this. In this report, Parexel experts share valuable insights designed to accelerate the development and market entry of these complex treatments.